Safety Study of LY3041658 in Healthy Participants

NCT02148627 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3041658 (SC)
DRUG: LY3041658 (IV)
DRUG: Placebo

Sponsor

Eli Lilly and Company